Business
Press Release Jul 21 2022
Zydus Lifesciences Limited has informed the Exchange about press release dated 21-Jul-2022 titled Zydus receives final approval from the USFDA for Norepinephrine Bitartrate Injection
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange about press release dated 21-Jul-2022 titled Zydus receives final approval from the USFDA for Norepinephrine Bitartrate Injection View Attachment","length":338,"tagName":"div"}]